Collegium Pharmaceutical (COLL): Assessing Valuation After Recent Share Price Momentum [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (COLL)
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.collegiumpharma.com
Company Research
Source: Yahoo! Finance
The company's performance raises interesting questions about its future direction and valuation. See our latest analysis for Collegium Pharmaceutical. Collegium Pharmaceutical's share price has soared 23% year-to-date, but with a more modest 1.7% total shareholder return over the past year, recent gains hint at fresh momentum rather than sustained long-term outperformance. The latest moves suggest investors are again weighing growth prospects against earlier risks and setbacks that kept a lid on returns. If you're curious which other pharma stocks are turning heads this year, check out our spotlight on sector leaders with big dividends in See the full list for free. But with the recent rally and valuations still below analyst targets, is Collegium Pharmaceutical currently trading at a discount? Or is the market already pricing in expectations for renewed growth ahead? Most Popular Narrative: 20.9% Undervalued Collegium Pharmaceutical's share price remains notably below the
Show less
Read more
Impact Snapshot
Event Time:
COLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COLL alerts
High impacting Collegium Pharmaceutical, Inc. news events
Weekly update
A roundup of the hottest topics
COLL
News
- Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- Collegium (COLL) Raises 2025 Revenue Guidance—Is Profitability Momentum Built to Last? [Yahoo! Finance]Yahoo! Finance
- Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Collegium to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
COLL
Earnings
- 11/6/25 - Beat
COLL
Sec Filings
- 11/14/25 - Form 4
- 11/14/25 - Form 4
- 11/13/25 - Form SCHEDULE
- COLL's page on the SEC website